Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Next Previous
Trial Profile

A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pafolacianine (Primary)
  • Indications Lung cancer
  • Focus Diagnostic use; Registrational
  • Acronyms Elucidate
  • Sponsors On Target Laboratories

Most Recent Events

  • 27 Mar 2023 Results (n=53) presented in an On Target Laboratories media release.
  • 27 Mar 2023 According to an On Target Laboratories media release, data from this study were published in the peer-reviewed Journal of Thoracic and Cardiovascular Surgery.
  • 16 Dec 2022 According to an On Target Laboratories media release, the trial is led by the principle investigator Sunil Singhal, MD, the William Maul Measey Professor in Surgical Research and director of the Center for Precision Surgery at Penn Medicine.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top